TEVA PHARMACEUTICAL INDUSTRIES LTD
TEVA, TEVJF · Pharmaceutical Preparations · 1.16B shares · +1%/yr ↑ dilution · EDGAR filings ↗
Reference price $32.19 · est. market cap ~$37.5B — last insider sale, 2026-06-18 (estimated from the dated SEC Form 4 price × shares outstanding — not a live quote)
Grade
B77Scaled global pharma franchise back in the black with top-decile ROIC and strong returns, tempered by heavy debt and litigation.
Strengths
- ROIC 17.5% (93rd pct), ROE 17.8% (81st pct) and operating margin 12.5% (84th pct) — returns near top of peer set
- Returned to $2.16B operating income with rising AUSTEDO/AJOVY/UZEDY innovative franchise and $2.4B free cash flow
Risks
- $16.8B debt load, interest coverage only 2.4x and quick ratio 0.80 (15th pct) constrain flexibility
- Generic price erosion, customer concentration and ongoing legal settlements; old laquinimod/glatiramer-ALS Phase 2 readouts were negative (non-core)
Notable findings
- Customer concentration~55% of revenue from one customer/distributor — In 2025, total revenues from sales of our generic medicines in all our business segments were $9,421 million, or 55% of our total revenues
- Fund exitedNotable fund(s) exited this quarter: VANGUARD GROUP INC
- Strong balance sheetStrong balance sheet — $3.6B cash & investments
- Notable holderHeld by 6 notable fund(s): FMR LLC, STATE STREET CORP, GOLDMAN SACHS GROUP INC +3 more (as of 2026-03-31)
- Insider sellingInsider selling — 37 open-market sale(s) by 11 insider(s) (cluster of 11 insiders, ~$76M, last 6mo) Form 4 ↗
Quarterly revenue
Last 4 quarters · from SEC filings.
Key metrics
Gross margin
51.8%
Operating margin
12.5%
Net margin
8.2%
Return on equity
17.8%
Return on assets
3.5%
ROIC
17.5%
Revenue growth (QoQ)
165.5%
Debt / equity
0.2×
Net debt / EBITDA
-0.5×
Interest coverage
2.4×
Current ratio
1.0×
EBITDA
$3.2B
Tangible book value
-$11.9B
Cash & investments
$3.6B
Stock comp / revenue
0.9%
Insider transactions · last 18 months
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| 2026-06-18 | Shields Matthew | Sell | 10.0K | $32.19 |
| 2026-06-11 | Kalif Eliyahu Sharon | Sell | 107K | $34.10 |
| 2026-06-05 | Crane Rosemary A | Option exercise | 14K | — |
| 2026-06-05 | Elstein Amir | Option exercise | 14K | — |
| 2026-06-05 | LIEBERMAN GERALD M | Option exercise | 14K | — |
| 2026-06-05 | Nisen Perry | Option exercise | 14K | — |
| 2026-06-05 | Satchi-Fainaro Ronit | Option exercise | 14K | — |
| 2026-06-05 | Zaks Tal Zvi | Option exercise | 14K | — |
| 2026-06-05 | MIGNONE ROBERTO | Option exercise | 14K | — |
| 2026-06-05 | Francis Richard D | Option exercise | 13K | — |
| 2026-06-05 | Francis Richard D | Sell | 6.2K | $34.35 |
| 2026-06-05 | BARER SOL J | Option exercise | 22K | — |
| 2026-06-05 | Lichtenstein Chen | Option exercise | 14K | — |
| 2026-06-03 | Shields Matthew | Option exercise | 16K | — |
| 2026-06-03 | Shields Matthew | Sell | 16K | $32.87 |
| 2026-05-14 | Lippman Evan | Option exercise | 12K | — |
| 2026-05-14 | Lippman Evan | Sell | 5.7K | $35.58 |
| 2026-05-14 | Lippman Evan | Option exercise | 74K | — |
| 2026-05-14 | Lippman Evan | Sell | 36K | $35.58 |
| 2026-05-14 | Kalif Eliyahu Sharon | Sell | 153K | $35.61 |
| 2026-05-06 | Weiss Amir | Sell | 11K | $36.00 |
| 2026-05-05 | Daniell Richard | Sell | 30K | $35.40 |
| 2026-05-01 | Sabag Mark | Sell | 144K | $34.99 |
| 2026-04-30 | Fox Christine | Sell | 21K | $35.31 |
| 2026-03-17 | Sabag Mark | Sell | 62K | $30.14 |
| 2026-03-05 | Fox Christine | Sell | 7.9K | $31.67 |
| 2026-03-05 | Sabag Mark | Option exercise | 16K | — |
| 2026-03-05 | Kalif Eliyahu Sharon | Option exercise | 20K | — |
| 2026-03-05 | Weiss Amir | Option exercise | 3.5K | — |
| 2026-03-05 | Francis Richard D | Option exercise | 42K | — |
| 2026-03-05 | Francis Richard D | Sell | 20K | $31.67 |
| 2026-03-05 | Fox Christine | Option exercise | 18K | — |
| 2026-03-05 | Hughes Eric A | Option exercise | 20K | — |
| 2026-03-05 | Hughes Eric A | Sell | 9.5K | $31.67 |
| 2026-03-05 | Daniell Richard | Option exercise | 17K | — |
| 2026-03-05 | Daniell Richard | Sell | 17K | $31.67 |
| 2026-03-05 | Jover Placid | Option exercise | 14K | — |
| 2026-03-05 | Jover Placid | Sell | 14K | $31.67 |
| 2026-03-05 | Savage Brian | Option exercise | 3.6K | — |
| 2026-03-05 | Savage Brian | Sell | 1.1K | $31.67 |
| 2026-03-05 | Shields Matthew | Option exercise | 17K | — |
| 2026-03-05 | Shields Matthew | Sell | 17K | $31.67 |
| 2026-03-04 | Francis Richard D | Option exercise | 50K | — |
| 2026-03-04 | Francis Richard D | Sell | 23K | $32.46 |
| 2026-03-04 | Daniell Richard | Option exercise | 34K | — |
| 2026-03-04 | Daniell Richard | Sell | 34K | $32.46 |
| 2026-03-04 | Daniell Richard | Option exercise | 20K | — |
| 2026-03-04 | Daniell Richard | Sell | 20K | $32.46 |
| 2026-03-04 | Daniell Richard | Sell | 37K | $32.95 |
| 2026-03-04 | Sabag Mark | Option exercise | 34K | — |
| 2026-03-04 | Sabag Mark | Option exercise | 19K | — |
| 2026-03-04 | Hughes Eric A | Option exercise | 23K | — |
| 2026-03-04 | Hughes Eric A | Sell | 11K | $32.46 |
| 2026-03-04 | Kalif Eliyahu Sharon | Option exercise | 34K | — |
| 2026-03-04 | Kalif Eliyahu Sharon | Option exercise | 23K | — |
| 2026-03-04 | Fox Christine | Option exercise | 20K | — |
| 2026-03-04 | Fox Christine | Sell | 9.1K | $32.46 |
| 2026-03-04 | Savage Brian | Option exercise | 4.7K | — |
| 2026-03-04 | Savage Brian | Sell | 1.5K | $32.46 |
| 2026-03-04 | Savage Brian | Option exercise | 3.5K | — |
| 2026-03-04 | Savage Brian | Sell | 1.2K | $32.46 |
| 2026-03-04 | Weiss Amir | Option exercise | 11K | — |
| 2026-03-04 | Weiss Amir | Option exercise | 5.7K | — |
| 2026-03-03 | Weiss Amir | Option exercise | 5.2K | — |
| 2026-03-03 | Daniell Richard | Option exercise | 62K | — |
| 2026-03-03 | Daniell Richard | Sell | 62K | $32.36 |
| 2026-03-03 | Daniell Richard | Option exercise | 141K | — |
| 2026-03-03 | Daniell Richard | Sell | 67K | $32.36 |
| 2026-03-03 | Sabag Mark | Option exercise | 25K | — |
| 2026-03-03 | Sabag Mark | Option exercise | 141K | — |
| 2026-03-03 | Savage Brian | Option exercise | 3.5K | — |
| 2026-03-03 | Savage Brian | Sell | 1.3K | $32.36 |
| 2026-03-03 | Francis Richard D | Option exercise | 67K | — |
| 2026-03-03 | Francis Richard D | Sell | 31K | $32.36 |
| 2026-03-03 | Francis Richard D | Option exercise | 891K | — |
| 2026-03-03 | Francis Richard D | Sell | 412K | $32.36 |
| 2026-03-03 | Kalif Eliyahu Sharon | Option exercise | 50K | — |
| 2026-03-03 | Kalif Eliyahu Sharon | Option exercise | 141K | — |
| 2026-03-03 | Hughes Eric A | Option exercise | 25K | — |
| 2026-03-03 | Hughes Eric A | Sell | 12K | $32.36 |
| 2026-03-03 | Hughes Eric A | Option exercise | 141K | — |
| 2026-03-03 | Hughes Eric A | Sell | 69K | $32.36 |
| 2026-02-26 | Kalif Eliyahu Sharon | Sell | 346K | $33.64 |
| 2026-02-15 | Francis Richard D | Sell | 286K | $34.22 |
| 2026-02-15 | Francis Richard D | Option exercise | 162K | — |
| 2026-02-15 | Francis Richard D | Sell | 162K | $34.22 |
| 2026-02-15 | Francis Richard D | Option exercise | 620K | — |
| 2025-12-16 | Weiss Amir | Sell | 12K | $30.20 |
| 2025-12-16 | MIGNONE ROBERTO | Sell | 77K | $30.24 |
| 2025-12-09 | Daniell Richard | Option exercise | 15K | $16.99 |
| 2025-12-09 | Sabag Mark | Sell | 119K | $28.75 |
| 2025-12-09 | Sabag Mark | Sell | 98K | $28.70 |
| 2025-12-09 | Sabag Mark | Option exercise | 119K | $18.61 |
| 2025-12-09 | Daniell Richard | Sell | 115K | $28.68 |
| 2025-12-09 | Daniell Richard | Option exercise | 100K | $18.61 |
| 2025-12-02 | Lichtenstein Chen | Option exercise | 4.8K | — |
| 2025-11-26 | MIGNONE ROBERTO | Sell | 50K | $26.03 |
| 2025-11-20 | Fox Christine | Option exercise | 63K | — |
| 2025-11-20 | Fox Christine | Sell | 28K | $24.78 |
| 2025-11-14 | Fox Christine | Sell | 30K | $25.11 |
| 2025-11-06 | Weiss Amir | Sell | 12K | $24.44 |
| 2025-11-06 | MIGNONE ROBERTO | Sell | 200K | $24.11 |
| 2025-09-05 | McAvoy David R. | Buy | 1.1K | $18.86 |
| 2025-08-01 | Hughes Eric A | Option exercise | 53K | — |
| 2025-08-01 | Hughes Eric A | Sell | 53K | $15.16 |
| 2025-08-01 | Jover Placid | Sell | 6.1K | $15.16 |
| 2025-08-01 | Jover Placid | Option exercise | 13K | — |
| 2025-06-12 | Kalif Eliyahu Sharon | Sell | 56K | $17.08 |
| 2025-06-06 | Zaks Tal Zvi | Option exercise | 9.6K | — |
| 2025-06-06 | MIGNONE ROBERTO | Option exercise | 9.6K | — |
| 2025-06-06 | Vergis Janet S. | Option exercise | 9.6K | — |
| 2025-06-06 | Shalev Varda | Option exercise | 9.6K | — |
| 2025-06-06 | Satchi-Fainaro Ronit | Option exercise | 9.6K | — |
| 2025-06-06 | Nisen Perry | Option exercise | 9.6K | — |
| 2025-06-06 | LIEBERMAN GERALD M | Option exercise | 9.6K | — |
| 2025-06-06 | Elstein Amir | Option exercise | 9.6K | — |
| 2025-06-06 | Crane Rosemary A | Option exercise | 9.6K | — |
| 2025-06-06 | BARER SOL J | Option exercise | 17K | — |
| 2025-06-03 | Shields Matthew | Option exercise | 16K | — |
| 2025-06-03 | Shields Matthew | Sell | 6.2K | $17.02 |
| 2025-05-08 | Sabag Mark | Sell | 338K | $18.04 |
| 2025-03-05 | Hughes Eric A | Sell | 8.1K | $15.91 |
| 2025-03-05 | Daniell Richard | Sell | 30K | $15.91 |
| 2025-03-05 | Francis Richard D | Sell | 8.3K | $15.91 |
| 2025-03-05 | Weiss Amir | Option exercise | 3.6K | — |
| 2025-03-05 | Kalif Eliyahu Sharon | Option exercise | 21K | — |
| 2025-03-05 | Sabag Mark | Option exercise | 24K | — |
| 2025-03-05 | Daniell Richard | Option exercise | 23K | — |
| 2025-03-05 | Daniell Richard | Sell | 23K | $15.91 |
| 2025-03-05 | Daniell Richard | Sell | 48K | $15.90 |
| 2025-03-05 | Daniell Richard | Sell | 12K | $15.91 |
| 2025-03-05 | Fox Christine | Sell | 2.1K | $15.91 |
| 2025-03-05 | McAvoy David R. | Sell | 1.7K | $15.91 |
| 2025-03-05 | Daniell Richard | Sell | 7.1K | $15.91 |
| 2025-03-04 | Hughes Eric A | Sell | 15K | $15.73 |
| 2025-03-04 | Weiss Amir | Option exercise | 11K | — |
| 2025-03-04 | Weiss Amir | Option exercise | 5.7K | — |
| 2025-03-04 | Fox Christine | Option exercise | 20K | — |
| 2025-03-04 | Fox Christine | Sell | 4.0K | $15.73 |
| 2025-03-04 | McAvoy David R. | Option exercise | 17K | — |
| 2025-03-04 | McAvoy David R. | Sell | 3.1K | $15.73 |
| 2025-03-04 | Kalif Eliyahu Sharon | Option exercise | 34K | — |
| 2025-03-04 | Kalif Eliyahu Sharon | Option exercise | 23K | — |
| 2025-03-04 | Kalif Eliyahu Sharon | Option exercise | 183K | — |
| 2025-03-04 | Hughes Eric A | Option exercise | 23K | — |
| 2025-03-04 | Sabag Mark | Option exercise | 34K | — |
| 2025-03-04 | Sabag Mark | Option exercise | 19K | — |
| 2025-03-04 | Sabag Mark | Option exercise | 183K | — |
| 2025-03-04 | Daniell Richard | Option exercise | 34K | — |
| 2025-03-04 | Daniell Richard | Sell | 22K | $15.73 |
| 2025-03-04 | Daniell Richard | Option exercise | 20K | — |
| 2025-03-04 | Daniell Richard | Sell | 13K | $15.73 |
| 2025-03-04 | Daniell Richard | Option exercise | 183K | — |
| 2025-03-04 | Daniell Richard | Sell | 56K | $15.73 |
| 2025-03-04 | Francis Richard D | Option exercise | 50K | — |
| 2025-03-04 | Francis Richard D | Sell | 16K | $15.73 |
| 2025-03-04 | Daniell Richard | Sell | 13K | $15.56 |
| 2025-03-04 | Hughes Eric A | Sell | 5.2K | $15.56 |
| 2025-03-04 | Francis Richard D | Sell | 6.5K | $15.56 |
| 2025-03-03 | Daniell Richard | Option exercise | 62K | — |
| 2025-03-03 | Kalif Eliyahu Sharon | Option exercise | 50K | — |
| 2025-03-03 | Weiss Amir | Option exercise | 5.2K | — |
| 2025-03-03 | Sabag Mark | Option exercise | 25K | — |
| 2025-03-03 | Daniell Richard | Sell | 49K | $16.19 |
| 2025-03-03 | Hughes Eric A | Option exercise | 25K | — |
| 2025-03-03 | Hughes Eric A | Sell | 20K | $16.19 |
| 2025-03-03 | Francis Richard D | Option exercise | 67K | — |
| 2025-03-03 | Francis Richard D | Sell | 25K | $16.19 |
| 2025-02-28 | Kalif Eliyahu Sharon | Sell | 56K | $16.21 |
| 2025-02-18 | Francis Richard D | Sell | 76K | $16.95 |
| 2025-02-15 | Francis Richard D | Option exercise | 162K | — |
| 2025-02-12 | Sabag Mark | Sell | 178K | $16.25 |
All non-derivative Form 4 activity (SEC), newest first.
Clinical trials
| Trial | Title | Phase | Status | Primary completion |
|---|---|---|---|---|
| NCT00745615 ↗ | An Extension Study of LAQ/5062 Exploring the Long Term Safety, Tolerability and Clinical Effect Parameters During the Disease Relapsing Remitting Multiple Sclerosis | PHASE2 | Terminated | 2017-07-23 |
| NCT02092077 ↗ | A Phase 2, Safety and Dose-Finding Study in Treatment-Naive, Pre-Pubertal, Growth Hormone-Deficient Children Growth Hormone-Deficiency | PHASE2 | Terminated | 2016-04-30 |
| NCT01123070 ↗ | TL011 in Severe, Active Rheumatoid Arthritis Patients Rheumatoid Arthritis | PHASE1 | Completed | 2012-04-23 |
| NCT00326625 ↗ | Clinical Trial of Glatiramer Acetate in Amyotrophic Lateral Sclerosis (ALS) Amyotrophic Lateral Sclerosis | PHASE2 | Completed | 2008-06-17 |
Source: ClinicalTrials.gov (U.S. NIH) · active studies first.
Supply chain
Customers (0)
Suppliers (10)
- Alvotech
- Medincell
- Modag
- Sanofi
- Royalty Pharma
- Biolojic
- Launch Therapeutics
- mAbxience
- ANI PHARMACEUTICALS INC
- HALOZYME THERAPEUTICS, INC.
Named in the 10-K; linked when we track them.
Notable events (8-K)
| Date | Items | |
|---|---|---|
| 2026-05-28 | Shareholder vote | filing ↗ |
| 2026-04-29 | ResultsReg FDExhibits | filing ↗ |
| 2026-01-28 | ResultsExhibits | filing ↗ |
| 2026-01-12 | ResultsExhibits | filing ↗ |
| 2025-12-11 | Material agreementDebt obligationExhibits | filing ↗ |
| 2025-11-05 | ResultsExhibits | filing ↗ |
| 2025-07-30 | ResultsExhibits | filing ↗ |
| 2025-06-05 | Shareholder vote | filing ↗ |
Recent filings
| Form | Filed | Period | Accession |
|---|---|---|---|
| 8-K | 2026-05-28 | 2026-05-28 | 0001193125-26-245203 ↗ |
| 10-Q | 2026-04-29 | 2026-03-31 | 0001193125-26-191513 ↗ |
| 8-K | 2026-04-29 | 2026-04-29 | 0001171843-26-002796 ↗ |
| 10-K | 2026-02-03 | 2025-12-31 | 0001193125-26-034532 ↗ |
| 8-K | 2026-01-28 | 2026-01-28 | 0001171843-26-000462 ↗ |
| 8-K | 2026-01-12 | 2026-01-11 | 0001171843-26-000174 ↗ |
| 8-K | 2025-12-11 | 2025-12-10 | 0001193125-25-316063 ↗ |
| 10-Q | 2025-11-05 | 2025-09-30 | 0001193125-25-266895 ↗ |
| 8-K | 2025-11-05 | 2025-11-05 | 0001171843-25-007000 ↗ |
| 8-K | 2025-07-30 | 2025-07-30 | 0001171843-25-004808 ↗ |
| 10-Q | 2025-07-30 | 2025-06-30 | 0001193125-25-169296 ↗ |
| 8-K | 2025-06-05 | 2025-06-05 | 0001193125-25-135942 ↗ |